Antimicrobial Susceptibility Testing Market by Product (Automated System  Disks  MIC Strips  Media)  Method (Dilution  Diffusion)  Type (Antibacterial  Antifungal)  Application (Clinical  Drug Discovery)  End User (Labs  Hospitals) - Global Forecast to 20

Antimicrobial Susceptibility Testing Market by Product (Automated System Disks MIC Strips Media) Method (Dilution Diffusion) Type (Antibacterial Antifungal) Application (Clinical Drug Discovery) End User (Labs Hospitals) - Global Forecast to 20

MarketsandMarkets | ID: 1524124123178 | Published at: 2018-01-26 | Pages: 166

  • €4.785,63


“The antimicrobial susceptibility testing market projected to grow at a CAGR of 5.1% during the forecast period.”
The global antimicrobial susceptibility testing market is projected to reach USD 3.47 billion by 2022 from USD 2.71 billion in 2017, at a CAGR of 5.1%. The major factors driving the growth of the market include the rising prevalence of infectious diseases; emergence of multidrug-resistance due to drug abuse; and increasing funds, research grants, and public-private investments. However, the high cost of automated antimicrobial susceptibility testing systems and unfavorable reimbursement scenario are restraining the growth of this market.

“The automated antimicrobial susceptibility testing segment is expected to grow at the highest rate during the forecast period.”
On the basis of product, the global antimicrobial susceptibility testing market is segmented automated laboratory instruments, manual antimicrobial susceptibility testing products, culture and growth media, and consumables. The automated laboratory instruments segment is estimated to witness the highest growth during the forecast period, primarily due to on-going technological advancements and increasing demand for faster susceptibility testing systems.

“The disk diffusion segment accounted for the largest share of antimicrobial susceptibility testing market by method.”
On the basis of method, the antimicrobial susceptibility testing market is segmented into disk diffusion, dilution, ETEST, automated antimicrobial susceptibility testing, and genotypic methods. The disk diffusion segment is expected to have the largest share of the market in 2017. This is mainly attributed to factors such as its low cost and flexible nature.

“The APAC market is expected to grow at the highest CAGR during the forecast period.”
Geographically, the antimicrobial susceptibility testing market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The APAC market is expected to register the highest growth rate during the forecast period. The fast growth of this segment is mainly due to the region’s large population and its mix of growing and developed economies, such as Japan, China, and India. Moreover, as markets in developed countries are increasingly becoming saturated, manufacturers and suppliers of antimicrobial susceptibility testing products are shifting their focus towards the Asian market, thereby driving the growth of this market during the forecast period.

Breakdown of supply-side primary interviews:
• By Company Type – Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
• By Designation – C-level – 26%, Director level – 30%, Others – 44%
• By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%

The major players in the market included are bioMérieux (France), BD (US), Danaher (US), Thermo Fisher (US), and Bio-Rad (US).

Research Coverage

This report studies the antimicrobial susceptibility testing market based on product, method, type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Reasons to Buy the Report:

This report focuses on various levels of analysis—industry trends, market ranking of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the antimicrobial susceptibility testing market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION 15

  • 1.1 OBJECTIVES OF THE STUDY 15
  • 1.2 MARKET DEFINITION 15
  • 1.3 MARKET SCOPE 16
    • 1.3.1 MARKETS COVERED 16
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY 17
  • 1.4 CURRENCY 17
  • 1.5 LIMITATIONS 17
  • 1.6 STAKEHOLDERS 18
    2 RESEARCH METHODOLOGY 19
  • 2.1 RESEARCH DATA 19
    • 2.1.1 SECONDARY DATA 21
      • 2.1.1.1 Key data from secondary sources 21
    • 2.1.2 PRIMARY DATA 23
      • 2.1.2.1 Key data from primary sources 23
      • 2.1.2.2 Breakdown of primaries 24
  • 2.2 MARKET SIZE ESTIMATION 24
    • 2.2.1 BOTTOM-UP APPROACH 25
    • 2.2.2 TOP-DOWN APPROACH 25
  • 2.3 DATA TRIANGULATION METHODOLOGY 26
  • 2.4 ASSUMPTIONS FOR THE STUDY 27
    3 EXECUTIVE SUMMARY 28
    4 PREMIUM INSIGHTS 33
  • 4.1 ATTRACTIVE OPPORTUNITIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING 33
  • 4.2 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD 34
  • 4.3 GEOGRAPHIC ANALYSIS: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION & PRODUCT 35
  • 4.4 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE 36
  • 4.5 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION 36
  • 4.6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER 37
  • 4.7 GEOGRAPHICAL SNAPSHOT OF THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET 38

5 MARKET OVERVIEW 39

  • 5.1 INTRODUCTION 39
  • 5.2 MARKET DYNAMICS 39
    • 5.2.1 DRIVERS 40
      • 5.2.1.1 Rising prevalence of infectious diseases 40
      • 5.2.1.2 Increased funding, research grants, and public-private investments 41
      • 5.2.1.3 Technological advancements towards the development of rapid AST methods 41
      • 5.2.1.4 Emergence of multidrug resistance due to drug abuse 42
    • 5.2.2 RESTRAINTS 43
      • 5.2.2.1 Unfavorable reimbursement scenario 43
    • 5.2.3 OPPORTUNITIES 44
      • 5.2.3.1 Emerging markets to offer lucrative opportunities 44
      • 5.2.3.2 Initiatives to detect and control antimicrobial-resistant species 44
    • 5.2.4 CHALLENGES 45
      • 5.2.4.1 High cost of automated antimicrobial susceptibility testing systems 45
      • 5.2.4.2 Lack of coordination between regulatory bodies, clinical laboratories, and AST manufacturers 46
  • 5.3 MARKET TRENDS 47
    6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD 48
  • 6.1 INTRODUCTION 49
  • 6.2 DISK DIFFUSION 50
  • 6.3 AUTOMATED AST 50
  • 6.4 DILUTION 51
  • 6.5 ETEST 52
  • 6.6 GENOTYPIC METHODS 53
    7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT 55
  • 7.1 INTRODUCTION 56
  • 7.2 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS 57
    • 7.2.1 SUSCEPTIBILITY TESTING DISKS 59
    • 7.2.2 MIC STRIPS 60
    • 7.2.3 SUSCEPTIBILITY PLATES 61
  • 7.3 AUTOMATED LABORATORY INSTRUMENTS 62
  • 7.4 CULTURE AND GROWTH MEDIA 63
  • 7.5 CONSUMABLES 64

8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE 66

  • 8.1 INTRODUCTION 67
  • 8.2 ANTIBACTERIAL SUSCEPTIBILITY TESTING 68
  • 8.3 ANTIFUNGAL SUSCEPTIBILITY TESTING 69
  • 8.4 ANTIPARASITIC SUSCEPTIBILITY TESTING 70
  • 8.5 OTHER SUSCEPTIBILITY TESTING 71
    9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION 73
  • 9.1 INTRODUCTION 74
  • 9.2 CLINICAL DIAGNOSTICS 75
  • 9.3 DRUG DISCOVERY AND DEVELOPMENT 76
  • 9.4 EPIDEMIOLOGY 77
  • 9.5 OTHER APPLICATIONS 78
    10 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER 80
  • 10.1 INTRODUCTION 81
  • 10.2 DIAGNOSTIC LABORATORIES AND HOSPITALS 82
  • 10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 83
  • 10.4 RESEARCH AND ACADEMIC INSTITUTES 84
  • 10.5 CONTRACT RESEARCH ORGANIZATIONS 85
    11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION 87
  • 11.1 INTRODUCTION 88
  • 11.2 NORTH AMERICA 88
    • 11.2.1 US 93
    • 11.2.2 CANADA 96
  • 11.3 EUROPE 99
  • 11.4 ASIA PACIFIC 104
  • 11.5 REST OF THE WORLD 108
    12 COMPETITIVE LANDSCAPE 113
  • 12.1 INTRODUCTION 113
  • 12.2 RANKING OF PLAYERS, 2016 114
  • 12.3 COMPETITIVE SCENARIO 115
    • 12.3.1 PRODUCT LAUNCHES AND ENHANCEMENTS 115
    • 12.3.2 ACQUISITIONS 115
    • 12.3.3 AGREEMENTS AND COLLABORATIONS 116
    • 12.3.4 EXPANSIONS 116

13 COMPANY PROFILES 117
(Business Overview, Products Offered, Swot Anlysis, MnM View.)*

  • 13.1 BIOMÉRIEUX 117
  • 13.2 DANAHER 120
  • 13.3 BD 123
  • 13.4 THERMO FISHER 126
  • 13.5 BIO-RAD 131
  • 13.6 HI-MEDIA 134
  • 13.7 MERLIN 136
  • 13.8 LIOFILCHEM 138
  • 13.9 ACCELERATE DIAGNOSTICS 141
  • 13.10 ALIFAX 143
  • 13.11 CREATIVE DIAGNOSTICS 145
  • 13.12 MERCK GROUP 147
  • 13.13 SYNBIOSIS 150
  • 13.14 BIOANALYSE 151
  • 13.15 ZHUHAI DL BIOTECH 152
*Business Overview, Products Offered, Swot Anlysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX 153
  • 14.1 INSIGHTS OF INDUSTRY EXPERTS 153
  • 14.2 DISCUSSION GUIDE 154
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 159
  • 14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 161
  • 14.5 AVAILABLE CUSTOMIZATIONS 163
  • 14.6 RELATED REPORTS 163
  • 14.7 AUTHOR DETAILS 164

LIST OF TABLES

TABLE 1 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD,
2015–2022 (USD MILLION) 49
TABLE 2 GLOBAL DISK DIFFUSION MARKET, BY REGION, 2015–2022 (USD MILLION) 50
TABLE 3 GLOBAL AUTOMATED AST MARKET, BY REGION, 2015–2022 (USD MILLION) 51
TABLE 4 GLOBAL DILUTION MARKET, BY REGION, 2015–2022 (USD MILLION) 52
TABLE 5 GLOBAL ETEST MARKET, BY REGION, 2015–2022 (USD MILLION) 53
TABLE 6 GLOBAL GENOTYPIC METHODS MARKET, BY REGION, 2015–2022 (USD MILLION) 54
TABLE 7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 57
TABLE 8 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET,
BY TYPE, 2015–2022 (USD MILLION) 58
TABLE 9 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET,
BY REGION, 2015–2022 (USD MILLION) 59
TABLE 10 SUSCEPTIBILITY TESTING DISKS MARKET, BY REGION, 2015–2022 (USD MILLION) 60
TABLE 11 MIC STRIPS MARKET, BY REGION, 2015–2022 (USD MILLION) 61
TABLE 12 SUSCEPTIBILITY PLATES MARKET, BY REGION, 2015–2022 (USD MILLION) 62
TABLE 13 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY REGION,
2015–2022 (USD MILLION) 63
TABLE 14 CULTURE AND GROWTH MARKET, BY REGION, 2015–2022 (USD MILLION) 64
TABLE 15 CONSUMABLES MARKET, BY REGION, 2015–2022 (USD MILLION) 65
TABLE 16 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE,
2015–2022 (USD MILLION) 67
TABLE 17 ANTIBACTERIAL SUSCEPTIBILITY TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 69
TABLE 18 ANTIFUNGAL SUSCEPTIBILITY TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 70
TABLE 19 ANTIPARASITIC SUSCEPTIBILITY TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 71
TABLE 20 OTHER SUSCEPTIBILITY TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 72
TABLE 21 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 75
TABLE 22 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2015–2022 (USD MILLION) 76
TABLE 23 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2015–2022 (USD MILLION) 77
TABLE 24 GLOBAL EPIDEMIOLOGY MARKET, BY REGION, 2015–2022 (USD MILLION) 78
TABLE 25 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 79
TABLE 26 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER,
2015–2022 (USD MILLION) 82
TABLE 27 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DIAGNOSTIC LABORATORIES AND HOSPITALS, BY REGION, 2015–2022 (USD MILLION) 83
TABLE 28 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION) 84
TABLE 29 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2015–2022 (USD MILLION) 85
TABLE 30 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CROS MARKET,
BY REGION, 2015–2022 (USD MILLION) 86
TABLE 31 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION,
2015–2022 (USD MILLION) 88
TABLE 32 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY COUNTRY, 2015–2022 (USD MILLION) 90
TABLE 33 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY PRODUCT, 2015–2022 (USD MILLION) 90
TABLE 34 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015–2022 (USD MILLION) 91
TABLE 35 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2015–2022 (USD MILLION) 91
TABLE 36 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET,
BY APPLICATION, 2015–2022 (USD MILLION) 92
TABLE 37 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015–2022 (USD MILLION) 92
TABLE 38 US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 94
TABLE 39 US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD,
2015–2022 (USD MILLION) 94
TABLE 40 US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE,
2015–2022 (USD MILLION) 95
TABLE 41 US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 95
TABLE 42 US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER,
2015–2022 (USD MILLION) 96
TABLE 43 CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 97
TABLE 44 CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD,
2015–2022 (USD MILLION) 97
TABLE 45 CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE,
2015–2022 (USD MILLION) 98
TABLE 46 CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 98
TABLE 47 CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015–2022 (USD MILLION) 99
TABLE 48 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 102
TABLE 49 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD,
2015–2022 (USD MILLION) 102
TABLE 50 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE,
2015–2022 (USD MILLION) 103
TABLE 51 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 103
TABLE 52 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015–2022 (USD MILLION) 104
TABLE 53 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 106
TABLE 54 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2015–2022 (USD MILLION) 106
TABLE 55 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE,
2015–2022 (USD MILLION) 107
TABLE 56 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 107
TABLE 57 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2015–2022 (USD MILLION) 108
TABLE 58 ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 110
TABLE 59 ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD,
2015–2022 (USD MILLION) 110
TABLE 60 ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE,
2015–2022 (USD MILLION) 111
TABLE 61 ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 111
TABLE 62 ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER,
2015–2022 (USD MILLION) 112


LIST OF FIGURES

FIGURE 1 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: RESEARCH METHODOLOGY STEPS 19
FIGURE 2 RESEARCH DESIGN 20
FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 4 DATA TRIANGULATION 26
FIGURE 5 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2017 28
FIGURE 6 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS WILL CONTINUE TO HOLD LARGEST SHARE IN 2022 29
FIGURE 7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2017 (USD MILLION) 29
FIGURE 8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2017 (USD MILLION) 30
FIGURE 9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2017 VS. 2022 (USD MILLION) 31
FIGURE 10 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 32
FIGURE 11 RISING PREVALENCE OF INFECTIOUS DISEASES—MAJOR FACTOR DRIVING MARKET GROWTH 33
FIGURE 12 DISK DIFFUSION SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2022 34
FIGURE 13 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS TO DOMINATE THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017 35
FIGURE 14 ANTIBACTERIAL SUSCEPTIBILITY TESTING SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2022 36
FIGURE 15 CLINICAL DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2022 36
FIGURE 16 HOSPITALS & DIAGNOSTIC LABORATORIES TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 37
FIGURE 17 ASIA PACIFIC TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD 38
FIGURE 18 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
FIGURE 19 DEATHS ATTRIBUTABLE TO ANTIMICROBIAL RESISTANCE PER YEAR BY 2050 43
FIGURE 20 DISK DIFFUSION SEGMENT TO DOMINATE THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING METHOD MARKET DURING THE FORECAST PERIOD 49
FIGURE 21 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 56
FIGURE 22 SUSCEPTIBILITY TESTING DISKS TO DOMINATE THE MANUAL AST PRODUCTS MARKET DURING THE FORECAST PERIOD 58
FIGURE 23 ANTIBACTERIAL TESTING SEGMENT TO DOMINATE THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017 67
FIGURE 24 CLINICAL DIAGNOSTICS SEGMENT TO DOMINATE THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017 74
FIGURE 25 DIAGNOSTIC LABORATORIES AND HOSPITALS SEGMENT TO DOMINATE THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2017 81
FIGURE 26 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT 89
FIGURE 27 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT 101
FIGURE 28 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT 105
FIGURE 29 ROW: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT 109
FIGURE 30 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, 2014–2017 113
FIGURE 31 BIOMÉRIEUX HELD THE LEADING POSITION IN THE GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2016 114
FIGURE 32 BIOMÉRIEUX: COMPANY SNAPSHOT 117
FIGURE 33 DANAHER: COMPANY SNAPSHOT 120
FIGURE 34 BD: COMPANY SNAPSHOT 123
FIGURE 35 THERMO FISHER: COMPANY SNAPSHOT 126
FIGURE 36 BIO-RAD: COMPANY SNAPSHOT 131
FIGURE 37 ACCELERATE DIAGNOSTICS: COMPANY SNAPSHOT 141
FIGURE 38 MERCK GROUP: COMPANY SNAPSHOT 147

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!